Qiagen NV at JPMorgan Healthcare Conference Transcript
Good afternoon. My name is Julia Qin. I work on the life science tools and diagnostics team at JPMorgan. It's my great pleasure to welcome you to our next company presentation today by QIAGEN.
As a reminder, there's a breakout after this session in the Olympic Room right down the hallway.
And with that, I'll turn it over to Thierry. Welcome.
Thank you so much, and good afternoon, and thanks for this opportunity to assess and highlight the situation of QIAGEN starting 2020 after what I could qualify as an eventful, I would say, 2019. And what I'd like to insist on, and we are really striving the company now to execute on what we consider to be a very differentiated Sample to Insight portfolio. If I had 3 takeaways for today, I would insist on the following. As I said before, despite the different events that we have been through, and I will come back to that in '19, I believe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
